Guangxi Liuzhou Pharm Co Ltd (603368) - Total Assets
Based on the latest financial reports, Guangxi Liuzhou Pharm Co Ltd (603368) holds total assets worth CN¥21.18 Billion CNY (≈ $3.10 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore investment intensity of Guangxi Liuzhou Pharm Co Ltd to see how much of total assets are deployed in long-term investments.
Guangxi Liuzhou Pharm Co Ltd - Total Assets Trend (2011–2024)
This chart illustrates how Guangxi Liuzhou Pharm Co Ltd's total assets have evolved over time, based on quarterly financial data. Check Guangxi Liuzhou Pharm Co Ltd (603368) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Guangxi Liuzhou Pharm Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Guangxi Liuzhou Pharm Co Ltd's total assets of CN¥21.18 Billion consist of 87.5% current assets and 12.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 17.3% |
| Accounts Receivable | CN¥11.45 Billion | 53.8% |
| Inventory | CN¥2.64 Billion | 12.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥223.13 Million | 1.1% |
| Goodwill | CN¥765.46 Million | 3.6% |
Asset Composition Trend (2011–2024)
This chart illustrates how Guangxi Liuzhou Pharm Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Guangxi Liuzhou Pharm Co Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guangxi Liuzhou Pharm Co Ltd's current assets represent 87.5% of total assets in 2024, a decrease from 96.3% in 2011.
- Cash Position: Cash and equivalents constituted 17.3% of total assets in 2024, down from 25.3% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 2.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 53.8% of total assets.
Guangxi Liuzhou Pharm Co Ltd Competitors by Total Assets
Key competitors of Guangxi Liuzhou Pharm Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998
|
China | CN¥112.28 Billion |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$46.10 Million |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥235.37 Billion |
Guangxi Liuzhou Pharm Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.64 | 1.60 | 1.56 |
| Quick Ratio | 1.35 | 1.35 | 1.37 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥7.10 Billion | CN¥7.31 Billion | CN¥4.57 Billion |
Guangxi Liuzhou Pharm Co Ltd - Advanced Valuation Insights
This section examines the relationship between Guangxi Liuzhou Pharm Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.91 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 5.5% |
| Total Assets | CN¥21.27 Billion |
| Market Capitalization | $920.11 Million USD |
Valuation Analysis
Below Book Valuation: The market values Guangxi Liuzhou Pharm Co Ltd's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Guangxi Liuzhou Pharm Co Ltd's assets grew by 5.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Guangxi Liuzhou Pharm Co Ltd (2011–2024)
The table below shows the annual total assets of Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥21.27 Billion ≈ $3.11 Billion |
+5.50% |
| 2023-12-31 | CN¥20.16 Billion ≈ $2.95 Billion |
+8.34% |
| 2022-12-31 | CN¥18.61 Billion ≈ $2.72 Billion |
+17.21% |
| 2021-12-31 | CN¥15.87 Billion ≈ $2.32 Billion |
+7.21% |
| 2020-12-31 | CN¥14.81 Billion ≈ $2.17 Billion |
+23.83% |
| 2019-12-31 | CN¥11.96 Billion ≈ $1.75 Billion |
+22.36% |
| 2018-12-31 | CN¥9.77 Billion ≈ $1.43 Billion |
+29.37% |
| 2017-12-31 | CN¥7.55 Billion ≈ $1.11 Billion |
+20.31% |
| 2016-12-31 | CN¥6.28 Billion ≈ $918.80 Million |
+45.85% |
| 2015-12-31 | CN¥4.30 Billion ≈ $629.95 Million |
+15.24% |
| 2014-12-31 | CN¥3.74 Billion ≈ $546.64 Million |
+38.47% |
| 2013-12-31 | CN¥2.70 Billion ≈ $394.78 Million |
+32.94% |
| 2012-12-31 | CN¥2.03 Billion ≈ $296.96 Million |
+28.96% |
| 2011-12-31 | CN¥1.57 Billion ≈ $230.28 Million |
-- |
About Guangxi Liuzhou Pharm Co Ltd
Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It offers various types of medicines, medical devices, consumables, and test reagents through online pharmacies and terminal physical pharmacies. The company was founded in 1981 and is based in Liuzhou, China.